

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.96597110 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.68601209 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.51174554 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.51174554 |
| 5 | negative regulation of cell killing (GO:0031342) | 5.40376343 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.40376343 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.36737446 |
| 8 | positive thymic T cell selection (GO:0045059) | 5.26759169 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.25936595 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 5.01677628 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 5.01677628 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.01677628 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.01677628 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.01677628 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 5.01677628 |
| 16 | negative T cell selection (GO:0043383) | 4.76825019 |
| 17 | negative thymic T cell selection (GO:0045060) | 4.73036985 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 4.66803121 |
| 19 | detection of other organism (GO:0098543) | 4.55599480 |
| 20 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.54625205 |
| 21 | detection of bacterium (GO:0016045) | 4.51316478 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 4.50518367 |
| 23 | thymic T cell selection (GO:0045061) | 4.48420123 |
| 24 | B cell receptor signaling pathway (GO:0050853) | 4.46581143 |
| 25 | positive T cell selection (GO:0043368) | 4.45860760 |
| 26 | response to peptidoglycan (GO:0032494) | 4.44370010 |
| 27 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.22972314 |
| 28 | response to interleukin-15 (GO:0070672) | 4.16950913 |
| 29 | T cell selection (GO:0045058) | 4.16948369 |
| 30 | cellular extravasation (GO:0045123) | 3.96876097 |
| 31 | macrophage activation involved in immune response (GO:0002281) | 3.96609770 |
| 32 | respiratory burst (GO:0045730) | 3.81312585 |
| 33 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.75829786 |
| 34 | leukocyte aggregation (GO:0070486) | 3.74455382 |
| 35 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.69236083 |
| 36 | DNA unwinding involved in DNA replication (GO:0006268) | 3.67684735 |
| 37 | negative regulation of interleukin-12 production (GO:0032695) | 3.67589041 |
| 38 | detection of external biotic stimulus (GO:0098581) | 3.62801894 |
| 39 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.61705620 |
| 40 | regulation of B cell differentiation (GO:0045577) | 3.59610444 |
| 41 | response to muramyl dipeptide (GO:0032495) | 3.55991309 |
| 42 | T cell migration (GO:0072678) | 3.48550584 |
| 43 | positive regulation of histone deacetylation (GO:0031065) | 3.48510906 |
| 44 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.47219867 |
| 45 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.45930854 |
| 46 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.45497526 |
| 47 | response to host immune response (GO:0052572) | 3.45497526 |
| 48 | immunoglobulin mediated immune response (GO:0016064) | 3.45205626 |
| 49 | cellular response to interleukin-15 (GO:0071350) | 3.44475303 |
| 50 | regulation of mast cell degranulation (GO:0043304) | 3.41137584 |
| 51 | negative regulation of phagocytosis (GO:0050765) | 3.41030411 |
| 52 | negative regulation of histone methylation (GO:0031061) | 3.40220007 |
| 53 | neutrophil activation (GO:0042119) | 3.38948473 |
| 54 | interferon-gamma production (GO:0032609) | 3.37286079 |
| 55 | negative regulation of T cell mediated immunity (GO:0002710) | 3.35732035 |
| 56 | positive regulation of B cell differentiation (GO:0045579) | 3.34245424 |
| 57 | T cell receptor signaling pathway (GO:0050852) | 3.33677147 |
| 58 | T cell costimulation (GO:0031295) | 3.27924903 |
| 59 | response to host (GO:0075136) | 3.27202168 |
| 60 | response to host defenses (GO:0052200) | 3.27202168 |
| 61 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.27202168 |
| 62 | tolerance induction (GO:0002507) | 3.25779843 |
| 63 | viral transcription (GO:0019083) | 3.24269869 |
| 64 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.23947767 |
| 65 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.23818449 |
| 66 | myeloid cell activation involved in immune response (GO:0002275) | 3.22499442 |
| 67 | pre-miRNA processing (GO:0031054) | 3.21958561 |
| 68 | regulation of leukocyte degranulation (GO:0043300) | 3.20689929 |
| 69 | lymphocyte costimulation (GO:0031294) | 3.20355579 |
| 70 | detection of biotic stimulus (GO:0009595) | 3.19986313 |
| 71 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.18987770 |
| 72 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.17700169 |
| 73 | granulocyte activation (GO:0036230) | 3.16119794 |
| 74 | protein localization to kinetochore (GO:0034501) | 3.07300747 |
| 75 | translational termination (GO:0006415) | 3.06826518 |
| 76 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.04585647 |
| 77 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.04125444 |
| 78 | detection of molecule of bacterial origin (GO:0032490) | 3.02986846 |
| 79 | natural killer cell differentiation (GO:0001779) | 3.02363167 |
| 80 | germinal center formation (GO:0002467) | 3.01516118 |
| 81 | type I interferon signaling pathway (GO:0060337) | 3.00169358 |
| 82 | cellular response to type I interferon (GO:0071357) | 3.00169358 |
| 83 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.00050830 |
| 84 | response to type I interferon (GO:0034340) | 2.99510516 |
| 85 | positive regulation of granulocyte differentiation (GO:0030854) | 2.97554723 |
| 86 | nuclear pore complex assembly (GO:0051292) | 2.96139750 |
| 87 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.96020620 |
| 88 | leukocyte degranulation (GO:0043299) | 2.95038064 |
| 89 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.94297247 |
| 90 | T cell homeostasis (GO:0043029) | 2.92397530 |
| 91 | regulation of tolerance induction (GO:0002643) | 2.91985299 |
| 92 | ribosomal small subunit assembly (GO:0000028) | 2.91431491 |
| 93 | defense response to protozoan (GO:0042832) | 2.90890575 |
| 94 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.88032473 |
| 95 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.88032473 |
| 96 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.86858021 |
| 97 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.85242679 |
| 98 | negative regulation of innate immune response (GO:0045824) | 2.84691591 |
| 99 | positive regulation of protein deacetylation (GO:0090312) | 2.83909983 |
| 100 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.83756994 |
| 101 | negative regulation of RNA splicing (GO:0033119) | 2.83149569 |
| 102 | NIK/NF-kappaB signaling (GO:0038061) | 2.81955080 |
| 103 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.81494432 |
| 104 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.81087123 |
| 105 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.80923840 |
| 106 | lymphocyte homeostasis (GO:0002260) | 2.80790190 |
| 107 | regulation of translational fidelity (GO:0006450) | 2.80214709 |
| 108 | activated T cell proliferation (GO:0050798) | 2.79451341 |
| 109 | positive regulation of mast cell activation (GO:0033005) | 2.77723309 |
| 110 | translational elongation (GO:0006414) | 2.76487791 |
| 111 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.75916607 |
| 112 | B cell mediated immunity (GO:0019724) | 2.75840454 |
| 113 | neutrophil mediated immunity (GO:0002446) | 2.75125624 |
| 114 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.74570420 |
| 115 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.74232222 |
| 116 | dosage compensation (GO:0007549) | 2.74095840 |
| 117 | regulation of T cell tolerance induction (GO:0002664) | 2.72944323 |
| 118 | nuclear pore organization (GO:0006999) | 2.72370474 |
| 119 | DNA duplex unwinding (GO:0032508) | 2.72209759 |
| 120 | regulation of histone H3-K9 methylation (GO:0051570) | 2.71992191 |
| 121 | modulation by virus of host process (GO:0019054) | 2.71939460 |
| 122 | megakaryocyte development (GO:0035855) | 2.71742550 |
| 123 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.71235931 |
| 124 | macrophage activation (GO:0042116) | 2.71222294 |
| 125 | leukocyte cell-cell adhesion (GO:0007159) | 2.71066298 |
| 126 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.71038208 |
| 127 | regulation of regulated secretory pathway (GO:1903305) | 2.70631352 |
| 128 | negative regulation of interleukin-6 production (GO:0032715) | 2.70626732 |
| 129 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.68625530 |
| 130 | B cell homeostasis (GO:0001782) | 2.68465956 |
| 131 | DNA geometric change (GO:0032392) | 2.68327562 |
| 132 | mitotic chromosome condensation (GO:0007076) | 2.66663640 |
| 133 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.66563355 |
| 134 | cellular response to interleukin-4 (GO:0071353) | 2.66190856 |
| 135 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.66011768 |
| 136 | protein localization to chromosome, centromeric region (GO:0071459) | 2.65500516 |
| 137 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.64927557 |
| 138 | endothelial tube morphogenesis (GO:0061154) | 2.64837675 |
| 139 | morphogenesis of an endothelium (GO:0003159) | 2.64837675 |
| 140 | positive regulation of lamellipodium assembly (GO:0010592) | 2.64837324 |
| 141 | cellular response to zinc ion (GO:0071294) | 2.64577175 |
| 142 | positive regulation of Rap GTPase activity (GO:0032854) | 2.60740726 |
| 143 | regulation of translational termination (GO:0006449) | 2.59387966 |
| 144 | positive regulation of interleukin-2 production (GO:0032743) | 2.58611198 |
| 145 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.57287957 |
| 146 | positive regulation of isotype switching (GO:0045830) | 2.57234360 |
| 147 | mitotic nuclear envelope disassembly (GO:0007077) | 2.54850439 |
| 148 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.54845525 |
| 149 | sister chromatid segregation (GO:0000819) | 2.54306660 |
| 150 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.53051885 |
| 151 | ncRNA 3-end processing (GO:0043628) | 2.52387225 |
| 152 | regulation of response to interferon-gamma (GO:0060330) | 2.52281764 |
| 153 | V(D)J recombination (GO:0033151) | 2.50014770 |
| 154 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.48430786 |
| 155 | response to laminar fluid shear stress (GO:0034616) | 2.48203301 |
| 156 | heterochromatin organization (GO:0070828) | 2.45973885 |
| 157 | translational initiation (GO:0006413) | 2.44392812 |
| 158 | cellular protein complex disassembly (GO:0043624) | 2.43309998 |
| 159 | mature B cell differentiation (GO:0002335) | 2.43148418 |
| 160 | membrane disassembly (GO:0030397) | 2.40744139 |
| 161 | nuclear envelope disassembly (GO:0051081) | 2.40744139 |
| 162 | viral life cycle (GO:0019058) | 2.39482716 |
| 163 | B cell proliferation (GO:0042100) | 2.39428276 |
| 164 | mRNA stabilization (GO:0048255) | 2.38838967 |
| 165 | RNA stabilization (GO:0043489) | 2.38838967 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.87060946 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 4.45785555 |
| 3 | * FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.69918174 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.48723885 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.34425197 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.25806042 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.12395172 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.84659229 |
| 9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.68625017 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.50561227 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.49615576 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.41459633 |
| 13 | * MAF_26560356_Chip-Seq_TH1_Human | 2.40197108 |
| 14 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.32608705 |
| 15 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.31154431 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.29402875 |
| 17 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.22818103 |
| 18 | * MYB_26560356_Chip-Seq_TH2_Human | 2.18226765 |
| 19 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.15584515 |
| 20 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.14259459 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.11512005 |
| 22 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.08472897 |
| 23 | * MYB_26560356_Chip-Seq_TH1_Human | 2.04432343 |
| 24 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.00683929 |
| 25 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.98133700 |
| 26 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.93838440 |
| 27 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.90365468 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.89927378 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.89883624 |
| 30 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.84523186 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.81305789 |
| 32 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.75478347 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.73734150 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.73273434 |
| 35 | MAF_26560356_Chip-Seq_TH2_Human | 1.72555500 |
| 36 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.71560511 |
| 37 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.71460396 |
| 38 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.70855041 |
| 39 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.70808027 |
| 40 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.70559027 |
| 41 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.70493987 |
| 42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.69243707 |
| 43 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.67414909 |
| 44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.66653945 |
| 45 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65017548 |
| 46 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63096142 |
| 47 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.59254385 |
| 48 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.58012472 |
| 49 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.45951109 |
| 50 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.45946765 |
| 51 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42270878 |
| 52 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.40312533 |
| 53 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.40132067 |
| 54 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38102109 |
| 55 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35991889 |
| 56 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.35110844 |
| 57 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33514441 |
| 58 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.33028412 |
| 59 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.32519343 |
| 60 | * P68_20966046_ChIP-Seq_HELA_Human | 1.30858969 |
| 61 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.29536993 |
| 62 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29368684 |
| 63 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.29365764 |
| 64 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.29224089 |
| 65 | SPI1_23127762_ChIP-Seq_K562_Human | 1.29171902 |
| 66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29149083 |
| 67 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.27554237 |
| 68 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.27020594 |
| 69 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24650131 |
| 70 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.24225417 |
| 71 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.22334104 |
| 72 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21752951 |
| 73 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21139403 |
| 74 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.19480588 |
| 75 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.19172728 |
| 76 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19031246 |
| 77 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.16832454 |
| 78 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.15708213 |
| 79 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.15605328 |
| 80 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13984650 |
| 81 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13555552 |
| 82 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.12951008 |
| 83 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.12509650 |
| 84 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11798347 |
| 85 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.10735016 |
| 86 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08979278 |
| 87 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08557225 |
| 88 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.07405804 |
| 89 | KDM2B_26808549_Chip-Seq_K562_Human | 1.05781480 |
| 90 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05229547 |
| 91 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04869524 |
| 92 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.04617338 |
| 93 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.04563998 |
| 94 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.03112155 |
| 95 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.03019496 |
| 96 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.01520343 |
| 97 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.99787451 |
| 98 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99263166 |
| 99 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.98304726 |
| 100 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.97464147 |
| 101 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97442858 |
| 102 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.97110073 |
| 103 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.96441292 |
| 104 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.95681731 |
| 105 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.95028684 |
| 106 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.94633933 |
| 107 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.93954406 |
| 108 | GATA1_22025678_ChIP-Seq_K562_Human | 0.93953248 |
| 109 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.93926647 |
| 110 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.93673947 |
| 111 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93556157 |
| 112 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.92435194 |
| 113 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.90317592 |
| 114 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.89873501 |
| 115 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89609306 |
| 116 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.89449246 |
| 117 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.88853904 |
| 118 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87929995 |
| 119 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.87584852 |
| 120 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86126227 |
| 121 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.85359437 |
| 122 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.84557880 |
| 123 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.84450587 |
| 124 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.84049220 |
| 125 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.83467824 |
| 126 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.83445331 |
| 127 | ATF3_27146783_Chip-Seq_COLON_Human | 0.82971784 |
| 128 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.81982519 |
| 129 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.81755543 |
| 130 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.81273311 |
| 131 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.79584210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 3.55512560 |
| 2 | MP0000685_abnormal_immune_system | 3.31921902 |
| 3 | MP0003724_increased_susceptibility_to | 3.27874635 |
| 4 | MP0001800_abnormal_humoral_immune | 3.21760663 |
| 5 | MP0003303_peritoneal_inflammation | 3.09070977 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.98507257 |
| 7 | MP0001790_abnormal_immune_system | 2.96904250 |
| 8 | MP0005387_immune_system_phenotype | 2.96904250 |
| 9 | MP0002396_abnormal_hematopoietic_system | 2.89002878 |
| 10 | MP0002398_abnormal_bone_marrow | 2.77053194 |
| 11 | MP0010352_gastrointestinal_tract_polyps | 2.67399271 |
| 12 | * MP0002452_abnormal_antigen_presenting | 2.48783405 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.47743790 |
| 14 | MP0005671_abnormal_response_to | 2.47521549 |
| 15 | * MP0002420_abnormal_adaptive_immunity | 2.45778888 |
| 16 | * MP0001819_abnormal_immune_cell | 2.40124954 |
| 17 | MP0002723_abnormal_immune_serum | 2.32638996 |
| 18 | MP0000703_abnormal_thymus_morphology | 2.30592995 |
| 19 | MP0004808_abnormal_hematopoietic_stem | 2.29268533 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.28104946 |
| 21 | MP0000716_abnormal_immune_system | 2.27977370 |
| 22 | MP0000689_abnormal_spleen_morphology | 2.27855003 |
| 23 | MP0002722_abnormal_immune_system | 2.27160129 |
| 24 | MP0005451_abnormal_body_composition | 2.21419681 |
| 25 | MP0008260_abnormal_autophagy | 2.14369036 |
| 26 | MP0002166_altered_tumor_susceptibility | 2.11987078 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 2.11201514 |
| 28 | MP0003436_decreased_susceptibility_to | 2.07106205 |
| 29 | MP0001873_stomach_inflammation | 2.05599318 |
| 30 | MP0003111_abnormal_nucleus_morphology | 2.03034539 |
| 31 | MP0009278_abnormal_bone_marrow | 2.00999676 |
| 32 | MP0003693_abnormal_embryo_hatching | 1.99900721 |
| 33 | MP0002429_abnormal_blood_cell | 1.99450553 |
| 34 | MP0003077_abnormal_cell_cycle | 1.97422780 |
| 35 | MP0002405_respiratory_system_inflammati | 1.95146009 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.93915816 |
| 37 | MP0005076_abnormal_cell_differentiation | 1.92249844 |
| 38 | MP0010094_abnormal_chromosome_stability | 1.91492649 |
| 39 | MP0003172_abnormal_lysosome_physiology | 1.88777062 |
| 40 | MP0004957_abnormal_blastocyst_morpholog | 1.82185543 |
| 41 | MP0005025_abnormal_response_to | 1.79285803 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.76205224 |
| 43 | MP0004947_skin_inflammation | 1.75213202 |
| 44 | MP0004381_abnormal_hair_follicle | 1.71801386 |
| 45 | MP0003705_abnormal_hypodermis_morpholog | 1.68186100 |
| 46 | MP0003866_abnormal_defecation | 1.64614835 |
| 47 | MP0000490_abnormal_crypts_of | 1.63702618 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.62197999 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.62197999 |
| 50 | MP0005058_abnormal_lysosome_morphology | 1.62160729 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.61192813 |
| 52 | MP0002006_tumorigenesis | 1.58961981 |
| 53 | MP0010307_abnormal_tumor_latency | 1.53729891 |
| 54 | MP0008057_abnormal_DNA_replication | 1.52803002 |
| 55 | MP0002132_abnormal_respiratory_system | 1.51233800 |
| 56 | MP0002419_abnormal_innate_immunity | 1.45147332 |
| 57 | MP0009785_altered_susceptibility_to | 1.42100260 |
| 58 | MP0002019_abnormal_tumor_incidence | 1.40954219 |
| 59 | MP0001730_embryonic_growth_arrest | 1.40311706 |
| 60 | MP0000350_abnormal_cell_proliferation | 1.38469323 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.34734212 |
| 62 | MP0003828_pulmonary_edema | 1.34733641 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.33593288 |
| 64 | MP0003566_abnormal_cell_adhesion | 1.29339728 |
| 65 | MP0010234_abnormal_vibrissa_follicle | 1.28642929 |
| 66 | MP0004510_myositis | 1.28312268 |
| 67 | MP0008961_abnormal_basal_metabolism | 1.24861655 |
| 68 | MP0000858_altered_metastatic_potential | 1.23282681 |
| 69 | MP0001853_heart_inflammation | 1.21318731 |
| 70 | MP0005023_abnormal_wound_healing | 1.15372033 |
| 71 | MP0003183_abnormal_peptide_metabolism | 1.13304692 |
| 72 | MP0002933_joint_inflammation | 1.11110420 |
| 73 | MP0002998_abnormal_bone_remodeling | 1.08653984 |
| 74 | MP0002148_abnormal_hypersensitivity_rea | 1.05593702 |
| 75 | MP0002086_abnormal_extraembryonic_tissu | 1.02428673 |
| 76 | MP0003656_abnormal_erythrocyte_physiolo | 1.00748093 |
| 77 | MP0002009_preneoplasia | 0.99563358 |
| 78 | MP0006054_spinal_hemorrhage | 0.99316371 |
| 79 | MP0003448_altered_tumor_morphology | 0.96333861 |
| 80 | MP0002080_prenatal_lethality | 0.95118083 |
| 81 | MP0000313_abnormal_cell_death | 0.94687087 |
| 82 | MP0003984_embryonic_growth_retardation | 0.93957798 |
| 83 | MP0004185_abnormal_adipocyte_glucose | 0.93610254 |
| 84 | MP0008007_abnormal_cellular_replicative | 0.93155550 |
| 85 | MP0001672_abnormal_embryogenesis/_devel | 0.93122429 |
| 86 | MP0005380_embryogenesis_phenotype | 0.93122429 |
| 87 | MP0002088_abnormal_embryonic_growth/wei | 0.92737656 |
| 88 | MP0001697_abnormal_embryo_size | 0.91838880 |
| 89 | MP0009840_abnormal_foam_cell | 0.91238887 |
| 90 | MP0003091_abnormal_cell_migration | 0.90180634 |
| 91 | MP0004197_abnormal_fetal_growth/weight/ | 0.89797221 |
| 92 | MP0009764_decreased_sensitivity_to | 0.89286875 |
| 93 | MP0005310_abnormal_salivary_gland | 0.88769907 |
| 94 | MP0000015_abnormal_ear_pigmentation | 0.87715530 |
| 95 | MP0000477_abnormal_intestine_morphology | 0.84045552 |
| 96 | MP0005083_abnormal_biliary_tract | 0.83049290 |
| 97 | MP0003075_altered_response_to | 0.83024515 |
| 98 | MP0005174_abnormal_tail_pigmentation | 0.81813495 |
| 99 | MP0001663_abnormal_digestive_system | 0.81524837 |
| 100 | MP0004883_abnormal_blood_vessel | 0.80659710 |
| 101 | MP0005075_abnormal_melanosome_morpholog | 0.80380067 |
| 102 | MP0000733_abnormal_muscle_development | 0.79530513 |
| 103 | MP0002277_abnormal_respiratory_mucosa | 0.79396276 |
| 104 | MP0000569_abnormal_digit_pigmentation | 0.79355731 |
| 105 | MP0008770_decreased_survivor_rate | 0.78660966 |
| 106 | MP0005166_decreased_susceptibility_to | 0.78467814 |
| 107 | MP0002877_abnormal_melanocyte_morpholog | 0.76312621 |
| 108 | MP0005621_abnormal_cell_physiology | 0.75841060 |
| 109 | MP0008058_abnormal_DNA_repair | 0.75682997 |
| 110 | MP0001986_abnormal_taste_sensitivity | 0.74902313 |
| 111 | MP0002084_abnormal_developmental_patter | 0.74782457 |
| 112 | MP0001533_abnormal_skeleton_physiology | 0.71549471 |
| 113 | MP0005390_skeleton_phenotype | 0.70427970 |
| 114 | MP0002085_abnormal_embryonic_tissue | 0.70193504 |
| 115 | MP0006082_CNS_inflammation | 0.69282906 |
| 116 | MP0003123_paternal_imprinting | 0.68758108 |
| 117 | MP0009763_increased_sensitivity_to | 0.68523568 |
| 118 | MP0003221_abnormal_cardiomyocyte_apopto | 0.66562752 |
| 119 | MP0003787_abnormal_imprinting | 0.65710396 |
| 120 | MP0008874_decreased_physiological_sensi | 0.63443327 |
| 121 | MP0003806_abnormal_nucleotide_metabolis | 0.61641485 |
| 122 | MP0000343_altered_response_to | 0.60577236 |
| 123 | MP0001849_ear_inflammation | 0.60164496 |
| 124 | MP0002925_abnormal_cardiovascular_devel | 0.60098551 |
| 125 | MP0005384_cellular_phenotype | 0.59804221 |
| 126 | MP0003453_abnormal_keratinocyte_physiol | 0.59387424 |
| 127 | MP0003795_abnormal_bone_structure | 0.59361293 |
| 128 | MP0008469_abnormal_protein_level | 0.59006263 |
| 129 | MP0001915_intracranial_hemorrhage | 0.58969469 |
| 130 | MP0004130_abnormal_muscle_cell | 0.58942122 |
| 131 | MP0001851_eye_inflammation | 0.58231107 |
| 132 | MP0000604_amyloidosis | 0.57546630 |
| 133 | MP0003279_aneurysm | 0.57318599 |
| 134 | MP0001348_abnormal_lacrimal_gland | 0.56860709 |
| 135 | MP0009931_abnormal_skin_appearance | 0.56280653 |
| 136 | MP0005666_abnormal_adipose_tissue | 0.55227363 |
| 137 | MP0000609_abnormal_liver_physiology | 0.53275994 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of macrophages (HP:0004311) | 4.85076318 |
| 2 | Recurrent bronchitis (HP:0002837) | 4.18014779 |
| 3 | IgM deficiency (HP:0002850) | 4.08630743 |
| 4 | T lymphocytopenia (HP:0005403) | 4.02761707 |
| 5 | Agammaglobulinemia (HP:0004432) | 4.02166006 |
| 6 | Recurrent viral infections (HP:0004429) | 4.00057428 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.99311573 |
| 8 | Verrucae (HP:0200043) | 3.97830368 |
| 9 | Papilloma (HP:0012740) | 3.97830368 |
| 10 | Orchitis (HP:0100796) | 3.92650053 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.91382654 |
| 12 | Gastrointestinal infarctions (HP:0005244) | 3.91088916 |
| 13 | Cellulitis (HP:0100658) | 3.78945434 |
| 14 | Abnormality of T cell number (HP:0011839) | 3.77116585 |
| 15 | Chronic otitis media (HP:0000389) | 3.68824648 |
| 16 | Panhypogammaglobulinemia (HP:0003139) | 3.68265033 |
| 17 | Optic neuritis (HP:0100653) | 3.57711572 |
| 18 | Retrobulbar optic neuritis (HP:0100654) | 3.57711572 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.43956319 |
| 20 | Gastrointestinal inflammation (HP:0004386) | 3.41318818 |
| 21 | Abnormality of T cells (HP:0002843) | 3.36434498 |
| 22 | Inflammation of the large intestine (HP:0002037) | 3.35026245 |
| 23 | Colitis (HP:0002583) | 3.30707135 |
| 24 | Nasal polyposis (HP:0100582) | 3.29689053 |
| 25 | Abnormality of the fingertips (HP:0001211) | 3.28477897 |
| 26 | Basal cell carcinoma (HP:0002671) | 3.27600183 |
| 27 | Encephalitis (HP:0002383) | 3.24092393 |
| 28 | Gingivitis (HP:0000230) | 3.20991436 |
| 29 | Hypochromic anemia (HP:0001931) | 3.17516689 |
| 30 | Pustule (HP:0200039) | 3.11726348 |
| 31 | Urticaria (HP:0001025) | 3.05427398 |
| 32 | Lymphopenia (HP:0001888) | 2.96930814 |
| 33 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.94978581 |
| 34 | Meningitis (HP:0001287) | 2.90157654 |
| 35 | Eczematoid dermatitis (HP:0000976) | 2.86436760 |
| 36 | Increased density of long bones (HP:0006392) | 2.84290976 |
| 37 | Hypochromic microcytic anemia (HP:0004840) | 2.83327370 |
| 38 | Abnormality of the nasal mucosa (HP:0000433) | 2.76712762 |
| 39 | Recurrent cutaneous fungal infections (HP:0011370) | 2.73676706 |
| 40 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.73676706 |
| 41 | Epistaxis (HP:0000421) | 2.70897714 |
| 42 | B lymphocytopenia (HP:0010976) | 2.70605961 |
| 43 | Abnormality of B cell number (HP:0010975) | 2.70605961 |
| 44 | Petechiae (HP:0000967) | 2.70128320 |
| 45 | Gastrointestinal stroma tumor (HP:0100723) | 2.68354059 |
| 46 | Abnormality of T cell physiology (HP:0011840) | 2.66023050 |
| 47 | Recurrent sinusitis (HP:0011108) | 2.64340528 |
| 48 | Keratoconjunctivitis sicca (HP:0001097) | 2.64156528 |
| 49 | Emphysema (HP:0002097) | 2.60720454 |
| 50 | Recurrent abscess formation (HP:0002722) | 2.56410995 |
| 51 | Combined immunodeficiency (HP:0005387) | 2.54936258 |
| 52 | Thrombocytosis (HP:0001894) | 2.51363320 |
| 53 | Increased IgM level (HP:0003496) | 2.50962671 |
| 54 | Hyperacusis (HP:0010780) | 2.43473066 |
| 55 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.42719625 |
| 56 | Increased IgE level (HP:0003212) | 2.40234931 |
| 57 | Spontaneous hematomas (HP:0007420) | 2.39645265 |
| 58 | Thyroiditis (HP:0100646) | 2.39106846 |
| 59 | Keratoconjunctivitis (HP:0001096) | 2.36622753 |
| 60 | Anorexia (HP:0002039) | 2.35987145 |
| 61 | Arterial thrombosis (HP:0004420) | 2.35839868 |
| 62 | IgA deficiency (HP:0002720) | 2.34047303 |
| 63 | Chronic sinusitis (HP:0011109) | 2.32911302 |
| 64 | Pulmonary infiltrates (HP:0002113) | 2.32011978 |
| 65 | Abnormal platelet volume (HP:0011876) | 2.31362655 |
| 66 | IgG deficiency (HP:0004315) | 2.29802016 |
| 67 | Slow saccadic eye movements (HP:0000514) | 2.28207073 |
| 68 | Hemoptysis (HP:0002105) | 2.28196607 |
| 69 | Mediastinal lymphadenopathy (HP:0100721) | 2.27474772 |
| 70 | Gingival bleeding (HP:0000225) | 2.26987594 |
| 71 | Increased serum ferritin (HP:0003281) | 2.26508755 |
| 72 | Hypertensive crisis (HP:0100735) | 2.24781884 |
| 73 | Cerebral aneurysm (HP:0004944) | 2.24441395 |
| 74 | Lymphoma (HP:0002665) | 2.23498336 |
| 75 | Severe combined immunodeficiency (HP:0004430) | 2.23135812 |
| 76 | Microcytic anemia (HP:0001935) | 2.22945308 |
| 77 | Purpura (HP:0000979) | 2.20788451 |
| 78 | Autoimmune thrombocytopenia (HP:0001973) | 2.19288561 |
| 79 | Episodic fever (HP:0001954) | 2.17574093 |
| 80 | Bronchitis (HP:0012387) | 2.12556268 |
| 81 | Vasculitis (HP:0002633) | 2.12049790 |
| 82 | Ulnar bowing (HP:0003031) | 2.09341506 |
| 83 | Recurrent bacterial skin infections (HP:0005406) | 2.08695287 |
| 84 | Short 4th metacarpal (HP:0010044) | 2.08641897 |
| 85 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.08641897 |
| 86 | Increased cerebral lipofuscin (HP:0011813) | 2.08522166 |
| 87 | Prolonged bleeding time (HP:0003010) | 2.07432085 |
| 88 | Abnormality of oral frenula (HP:0000190) | 2.03846024 |
| 89 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.02872070 |
| 90 | Vertebral arch anomaly (HP:0008438) | 2.02507608 |
| 91 | Hepatosplenomegaly (HP:0001433) | 2.01724073 |
| 92 | Pulmonary embolism (HP:0002204) | 2.00765661 |
| 93 | Hypergammaglobulinemia (HP:0010702) | 2.00190973 |
| 94 | Ependymoma (HP:0002888) | 1.99417289 |
| 95 | Obstructive lung disease (HP:0006536) | 1.98468496 |
| 96 | Chronic obstructive pulmonary disease (HP:0006510) | 1.98468496 |
| 97 | Osteomyelitis (HP:0002754) | 1.97408560 |
| 98 | Abnormality of iron homeostasis (HP:0011031) | 1.96178749 |
| 99 | Prominent nose (HP:0000448) | 1.95880788 |
| 100 | High pitched voice (HP:0001620) | 1.92836146 |
| 101 | Recurrent skin infections (HP:0001581) | 1.91630831 |
| 102 | Viral hepatitis (HP:0006562) | 1.91374101 |
| 103 | Chest pain (HP:0100749) | 1.91017415 |
| 104 | Heterotopia (HP:0002282) | 1.90527860 |
| 105 | Restrictive lung disease (HP:0002091) | 1.90357800 |
| 106 | Autoimmune hemolytic anemia (HP:0001890) | 1.89125522 |
| 107 | Cutaneous melanoma (HP:0012056) | 1.88635485 |
| 108 | Stomatitis (HP:0010280) | 1.87040512 |
| 109 | Broad palm (HP:0001169) | 1.87027797 |
| 110 | Recurrent otitis media (HP:0000403) | 1.87004801 |
| 111 | Skin ulcer (HP:0200042) | 1.85867460 |
| 112 | Eosinophilia (HP:0001880) | 1.85707961 |
| 113 | Acute hepatic failure (HP:0006554) | 1.85581426 |
| 114 | Increased mean platelet volume (HP:0011877) | 1.85355588 |
| 115 | Abnormality of the peritoneum (HP:0002585) | 1.84530620 |
| 116 | Bicuspid aortic valve (HP:0001647) | 1.84127653 |
| 117 | Premature loss of primary teeth (HP:0006323) | 1.84018707 |
| 118 | Glomerulopathy (HP:0100820) | 1.83739649 |
| 119 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.83415804 |
| 120 | Myositis (HP:0100614) | 1.83411914 |
| 121 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.83378672 |
| 122 | Reticulocytopenia (HP:0001896) | 1.81884834 |
| 123 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.79654003 |
| 124 | Polycythemia (HP:0001901) | 1.79185291 |
| 125 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.78892285 |
| 126 | Sepsis (HP:0100806) | 1.77927208 |
| 127 | Abnormal number of erythroid precursors (HP:0012131) | 1.77548039 |
| 128 | Subacute progressive viral hepatitis (HP:0006572) | 1.77101326 |
| 129 | Leukocytosis (HP:0001974) | 1.76640178 |
| 130 | Skin rash (HP:0000988) | 1.74650700 |
| 131 | Metaphyseal cupping (HP:0003021) | 1.74329150 |
| 132 | Macroorchidism (HP:0000053) | 1.73714184 |
| 133 | Deviation of the thumb (HP:0009603) | 1.73099700 |
| 134 | Recurrent lower respiratory tract infections (HP:0002783) | 1.71632987 |
| 135 | Granulocytopenia (HP:0001913) | 1.70379253 |
| 136 | Amaurosis fugax (HP:0100576) | 1.68390215 |
| 137 | Poikiloderma (HP:0001029) | 1.68134355 |
| 138 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.67146658 |
| 139 | Fatigue (HP:0012378) | 1.65540406 |
| 140 | Proximal placement of thumb (HP:0009623) | 1.65426458 |
| 141 | Persistence of primary teeth (HP:0006335) | 1.65025508 |
| 142 | Abnormality of eosinophils (HP:0001879) | 1.64393166 |
| 143 | Interstitial pulmonary disease (HP:0006530) | 1.64304529 |
| 144 | Spinal cord lesions (HP:0100561) | 1.63845650 |
| 145 | Syringomyelia (HP:0003396) | 1.63845650 |
| 146 | Dilatation of the ascending aorta (HP:0005111) | 1.61975353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.48661542 |
| 2 | MAP3K10 | 3.85999792 |
| 3 | EEF2K | 3.83653309 |
| 4 | PRPF4B | 3.51227408 |
| 5 | PKN2 | 3.23940799 |
| 6 | TRIB3 | 2.94375358 |
| 7 | STK10 | 2.73726230 |
| 8 | SMG1 | 2.44238705 |
| 9 | CDK12 | 2.18606707 |
| 10 | LRRK2 | 2.01123701 |
| 11 | JAK3 | 1.89565118 |
| 12 | ZAP70 | 1.80239883 |
| 13 | SIK2 | 1.79143558 |
| 14 | NEK2 | 1.72956815 |
| 15 | ITK | 1.71236597 |
| 16 | TYK2 | 1.70536908 |
| 17 | BTK | 1.64442722 |
| 18 | MAP3K3 | 1.62631851 |
| 19 | BLK | 1.61015172 |
| 20 | TXK | 1.54545816 |
| 21 | CDC7 | 1.54247080 |
| 22 | ERN1 | 1.49497849 |
| 23 | SYK | 1.48037970 |
| 24 | ALK | 1.46210974 |
| 25 | TTN | 1.45415922 |
| 26 | SIK3 | 1.41815790 |
| 27 | FGFR4 | 1.39572080 |
| 28 | IRAK3 | 1.30565293 |
| 29 | TAOK2 | 1.30536013 |
| 30 | CDK4 | 1.30088072 |
| 31 | MAP3K13 | 1.27688958 |
| 32 | HCK | 1.27652421 |
| 33 | CSF1R | 1.26935027 |
| 34 | MAP3K1 | 1.25141806 |
| 35 | CSK | 1.24060658 |
| 36 | KSR2 | 1.22007357 |
| 37 | JAK1 | 1.21248155 |
| 38 | CLK1 | 1.20445149 |
| 39 | TESK2 | 1.18611078 |
| 40 | PIM1 | 1.18141422 |
| 41 | LCK | 1.15379433 |
| 42 | RPS6KB2 | 1.13627896 |
| 43 | FGFR3 | 1.12439086 |
| 44 | MAP3K8 | 1.09180832 |
| 45 | FGR | 1.08785367 |
| 46 | SCYL2 | 1.07375059 |
| 47 | * GRK6 | 1.07284333 |
| 48 | MARK3 | 1.06669013 |
| 49 | PTK6 | 1.06058250 |
| 50 | RPS6KA4 | 1.05925484 |
| 51 | MAP2K3 | 1.04487470 |
| 52 | ICK | 1.01740702 |
| 53 | IRAK2 | 1.01417281 |
| 54 | TBK1 | 0.97455880 |
| 55 | PRKCH | 0.95080868 |
| 56 | IKBKE | 0.90418638 |
| 57 | FES | 0.89969930 |
| 58 | FLT3 | 0.89350030 |
| 59 | PDPK1 | 0.87339228 |
| 60 | TNK2 | 0.86618924 |
| 61 | STK4 | 0.85192491 |
| 62 | PASK | 0.80112001 |
| 63 | MAPK12 | 0.79232397 |
| 64 | TEC | 0.78381110 |
| 65 | MAP3K14 | 0.77532009 |
| 66 | TAOK1 | 0.77313837 |
| 67 | BRD4 | 0.73280538 |
| 68 | TGFBR1 | 0.71782830 |
| 69 | CDK6 | 0.71411047 |
| 70 | YES1 | 0.67383273 |
| 71 | LYN | 0.67375702 |
| 72 | JAK2 | 0.67262839 |
| 73 | MAP3K7 | 0.66981605 |
| 74 | RIPK1 | 0.66747273 |
| 75 | CDC42BPA | 0.66233345 |
| 76 | MELK | 0.64927921 |
| 77 | MAP2K2 | 0.63289323 |
| 78 | CAMKK1 | 0.62465038 |
| 79 | EPHB1 | 0.61490794 |
| 80 | RIPK4 | 0.61424172 |
| 81 | BMX | 0.59237754 |
| 82 | IKBKB | 0.58481496 |
| 83 | IRAK1 | 0.58468143 |
| 84 | PDK1 | 0.58260530 |
| 85 | TAOK3 | 0.56759187 |
| 86 | TYRO3 | 0.56648704 |
| 87 | NLK | 0.55008294 |
| 88 | ATR | 0.54651127 |
| 89 | CHEK1 | 0.54309392 |
| 90 | PRKD2 | 0.54222861 |
| 91 | TSSK6 | 0.52480819 |
| 92 | PRKCQ | 0.52365862 |
| 93 | MST4 | 0.51571397 |
| 94 | MTOR | 0.51555422 |
| 95 | HIPK2 | 0.51179833 |
| 96 | BUB1 | 0.50878953 |
| 97 | MAP3K6 | 0.50586773 |
| 98 | KIT | 0.50549654 |
| 99 | TLK1 | 0.50446073 |
| 100 | MATK | 0.50309439 |
| 101 | CDK9 | 0.49252222 |
| 102 | RPS6KA2 | 0.49064551 |
| 103 | MAPK11 | 0.48827243 |
| 104 | SIK1 | 0.47990639 |
| 105 | TGFBR2 | 0.47697380 |
| 106 | NME2 | 0.47212913 |
| 107 | BMPR2 | 0.46137144 |
| 108 | RAF1 | 0.45969399 |
| 109 | MAP3K2 | 0.45008321 |
| 110 | FYN | 0.44661656 |
| 111 | RPS6KA6 | 0.44645845 |
| 112 | PAK4 | 0.44446099 |
| 113 | SGK3 | 0.43896905 |
| 114 | RPS6KC1 | 0.43157959 |
| 115 | RPS6KL1 | 0.43157959 |
| 116 | MAPK7 | 0.41581943 |
| 117 | CDK2 | 0.41299713 |
| 118 | CDK7 | 0.40452970 |
| 119 | MAPKAPK2 | 0.40066593 |
| 120 | DYRK1B | 0.39885077 |
| 121 | WEE1 | 0.39806594 |
| 122 | PDGFRB | 0.38023920 |
| 123 | IRAK4 | 0.37597498 |
| 124 | KDR | 0.36995054 |
| 125 | CHUK | 0.36836973 |
| 126 | CAMK1D | 0.36756572 |
| 127 | MAP3K11 | 0.36338299 |
| 128 | RET | 0.35815738 |
| 129 | AURKB | 0.35455001 |
| 130 | STK11 | 0.35408599 |
| 131 | RPS6KA1 | 0.33843828 |
| 132 | MARK2 | 0.33583038 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.97621641 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.95961057 |
| 3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.32392541 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.13644625 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.02357603 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.99122146 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.97705444 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.94605233 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.89412927 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.86757878 |
| 11 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.86713831 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.84479906 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.78509041 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.74677526 |
| 15 | Mismatch repair_Homo sapiens_hsa03430 | 1.71420080 |
| 16 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.66574706 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.65983741 |
| 18 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.65621111 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.65393597 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.61998976 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.60337175 |
| 22 | Base excision repair_Homo sapiens_hsa03410 | 1.58525692 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.58075115 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.54338692 |
| 25 | Spliceosome_Homo sapiens_hsa03040 | 1.50802798 |
| 26 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.47444192 |
| 27 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.43298865 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.41692829 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.36846777 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.32322947 |
| 31 | Ribosome_Homo sapiens_hsa03010 | 1.32152820 |
| 32 | Hepatitis B_Homo sapiens_hsa05161 | 1.29640272 |
| 33 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.29379672 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.29186568 |
| 35 | HTLV-I infection_Homo sapiens_hsa05166 | 1.28103163 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.24108498 |
| 37 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.22904766 |
| 38 | Colorectal cancer_Homo sapiens_hsa05210 | 1.22453240 |
| 39 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.22029530 |
| 40 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.20971687 |
| 41 | RNA transport_Homo sapiens_hsa03013 | 1.20675599 |
| 42 | Platelet activation_Homo sapiens_hsa04611 | 1.20548657 |
| 43 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.20180386 |
| 44 | Cell cycle_Homo sapiens_hsa04110 | 1.18830383 |
| 45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.16787736 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.16615732 |
| 47 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.15848559 |
| 48 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.15744605 |
| 49 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13950212 |
| 50 | Apoptosis_Homo sapiens_hsa04210 | 1.11768119 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.11183590 |
| 52 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.10046601 |
| 53 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.02955612 |
| 54 | Asthma_Homo sapiens_hsa05310 | 0.99569127 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99388090 |
| 56 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.98205761 |
| 57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.97750809 |
| 58 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.96332063 |
| 59 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93604868 |
| 60 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.92798978 |
| 61 | Influenza A_Homo sapiens_hsa05164 | 0.92558056 |
| 62 | Phagosome_Homo sapiens_hsa04145 | 0.91559455 |
| 63 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.90718038 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.89998884 |
| 65 | Endometrial cancer_Homo sapiens_hsa05213 | 0.87503040 |
| 66 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.87122154 |
| 67 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.86267093 |
| 68 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.85086153 |
| 69 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.84681155 |
| 70 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.84558218 |
| 71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.83871095 |
| 72 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.83477885 |
| 73 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.82324851 |
| 74 | Tuberculosis_Homo sapiens_hsa05152 | 0.79394076 |
| 75 | Glioma_Homo sapiens_hsa05214 | 0.78448020 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78249448 |
| 77 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.76675246 |
| 78 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.75539428 |
| 79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75528593 |
| 80 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.75527194 |
| 81 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.75195809 |
| 82 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.75094059 |
| 83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74997267 |
| 84 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74103341 |
| 85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.73557078 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73512493 |
| 87 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.70762652 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70589992 |
| 89 | Homologous recombination_Homo sapiens_hsa03440 | 0.69037630 |
| 90 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.67436112 |
| 91 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.67252779 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67247543 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67213155 |
| 94 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.66726764 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65460765 |
| 96 | Legionellosis_Homo sapiens_hsa05134 | 0.65261219 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65125610 |
| 98 | Lysosome_Homo sapiens_hsa04142 | 0.64958800 |
| 99 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64610363 |
| 100 | Hepatitis C_Homo sapiens_hsa05160 | 0.63727089 |
| 101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.62649569 |
| 102 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61979910 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60537027 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.58361717 |
| 105 | Prostate cancer_Homo sapiens_hsa05215 | 0.58215684 |
| 106 | Lysine degradation_Homo sapiens_hsa00310 | 0.57459087 |
| 107 | Salmonella infection_Homo sapiens_hsa05132 | 0.57188680 |
| 108 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56511815 |
| 109 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.55291288 |
| 110 | Pertussis_Homo sapiens_hsa05133 | 0.54387184 |
| 111 | Adherens junction_Homo sapiens_hsa04520 | 0.52958166 |
| 112 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.52798787 |
| 113 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52406509 |
| 114 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52180377 |
| 115 | Pathways in cancer_Homo sapiens_hsa05200 | 0.52062284 |
| 116 | RNA degradation_Homo sapiens_hsa03018 | 0.51736298 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51265655 |
| 118 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50760423 |
| 119 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49976239 |
| 120 | * Endocytosis_Homo sapiens_hsa04144 | 0.49463951 |
| 121 | Bladder cancer_Homo sapiens_hsa05219 | 0.48506048 |
| 122 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47902898 |
| 123 | Focal adhesion_Homo sapiens_hsa04510 | 0.47848754 |
| 124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46853397 |
| 125 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46694895 |
| 126 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.44934449 |
| 127 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44203344 |
| 128 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.43147404 |

